Tandem Diabetes Care (TNDM) Change in Inventory (2013 - 2026)

Tandem Diabetes Care has reported Change in Inventory for 14 years, with the latest figure at -$1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 79.93% year-over-year to -$1.9 million; the trailing twelve-month figure through Mar 2026 stood at -$17.1 million (down 39.89% YoY), and the FY2025 full-year result was -$24.8 million, down 327.13% from the prior year.
• Change in Inventory for Q1 2026 stood at -$1.9 million, up from -$7.6 million in the prior quarter.
• The five-year high for Change in Inventory was $19.9 million in Q1 2023, with the low at -$10.4 million in Q3 2024.
• Historically, Change in Inventory has averaged $3.3 million across 5 years, with a median of -$595000.0 in 2024.
• Annual changes were most pronounced in 2022 — Change in Inventory soared 7149.58% — and 2025, when it slumped 1171.26%.
• Tandem Diabetes Care's Change in Inventory stood at $5.4 million in 2022, then surged by 147.48% to $13.3 million in 2023, then tumbled by 104.46% to -$595000.0 in 2024, then tumbled by 1171.26% to -$7.6 million in 2025, then soared by 74.52% to -$1.9 million in 2026.
• The last three Change in Inventory figures came in at -$1.9 million (Q1 2026), -$7.6 million (Q4 2025), and -$5.2 million (Q3 2025), per Business Quant data.